Loretta Boesing
@lorettaboesing.bsky.social
Patient advocate for a better future of pharmaceutical care for patients like my son, a liver transplant survivor 💚💙
When UHC used their PBM, Optum, to pay their own mail order pharmacy, also called Optum, huge markups on specialty medications, none of that count it as profit to United.
January 24, 2025 at 11:32 AM
When UHC used their PBM, Optum, to pay their own mail order pharmacy, also called Optum, huge markups on specialty medications, none of that count it as profit to United.
Reposted by Loretta Boesing
My Dad was getting his cancer pills last year through his hospital pharmacy at no cost and is now being faced with a $2000 per month copay because it moved to Optum specialty pharmacy. It is incredibly upsetting to know he cannot afford the meds his oncologist prescribed.
January 15, 2025 at 11:25 PM
My Dad was getting his cancer pills last year through his hospital pharmacy at no cost and is now being faced with a $2000 per month copay because it moved to Optum specialty pharmacy. It is incredibly upsetting to know he cannot afford the meds his oncologist prescribed.
Reposted by Loretta Boesing
Also, CVS Health’s Caremark, Cigna’s ESI, and United Health Group’s Optum were involved with “rigging pharmaceutical supply chain competition in their favor, forcing patients to pay” billions more for insulin.
“By 2019 one out of every four insulin patients was unable to afford their medication.”
“By 2019 one out of every four insulin patients was unable to afford their medication.”
FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices
Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group pur
www.ftc.gov
January 17, 2025 at 4:18 AM
Also, CVS Health’s Caremark, Cigna’s ESI, and United Health Group’s Optum were involved with “rigging pharmaceutical supply chain competition in their favor, forcing patients to pay” billions more for insulin.
“By 2019 one out of every four insulin patients was unable to afford their medication.”
“By 2019 one out of every four insulin patients was unable to afford their medication.”
MSN
www.msn.com
January 14, 2025 at 12:31 AM